ALX Oncology Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	32.28	16.37	17.57	22.41	48.82	363.67
Short-Term Investments	108.04	28.42	110.19	160.33	217.39	-
Cash & Short-Term Investments	140.32	44.79	127.76	182.74	266.21	363.67
Cash Growth	43.44%	-64.94%	-30.09%	-31.36%	-26.80%	-16.25%
Other Current Assets	5.24	5.94	6.6	5.92	4.76	3.35
Total Current Assets	145.56	50.73	134.35	188.66	270.97	367.02
Net Property, Plant & Equipment	1.05	1.2	2.91	3.59	3.89	0.9
Long-Term Investments	28.78	3.49	3.52	35.41	16.7	-
Other Long-Term Assets	2.93	3.63	6.99	14.89	14.93	12.27
Total Assets	178.33	59.05	147.78	242.55	306.49	380.18
Accounts Payable	3.85	4.91	4.65	9.13	9.72	5.39
Accrued Expenses	11.11	14.42	13.42	26.87	18.6	9.9
Current Portion of Long-Term Debt	5.22	5.22	0.44	-	-	-
Total Current Liabilities	20.18	24.55	18.5	36	28.33	15.3
Long-Term Debt	3.3	4.53	9.47	9.64	9.39	-
Other Long-Term Liabilities	3.51	3.98	6.19	7.2	5.31	1.84
Total Long-Term Liabilities	6.8	8.51	15.66	16.84	14.7	1.84
Total Liabilities	26.98	33.07	34.16	52.84	43.03	17.13
Common Stock	0.14	0.05	0.05	0	0.04	0.04
Additional Paid-in Capital	892.2	748.72	734.41	675.68	589.74	564.99
Accumulated Other Comprehensive Income	-0.25	0.03	0.28	0.26	-0.85	-
Retained Earnings	-740.74	-722.82	-621.12	-486.27	-325.47	-201.99
Shareholders' Equity	151.35	25.98	113.62	189.71	263.46	363.05
Total Liabilities & Equity	178.33	59.05	147.78	242.55	306.49	380.18
Total Debt	8.51	9.75	9.9	9.64	9.39	0
Net Cash (Debt)	131.81	35.04	117.85	173.1	256.82	363.67
Net Cash Growth	276.17%	-70.27%	-31.91%	-32.60%	-29.38%	-16.25%
Net Cash Per Share	1.98	0.65	2.26	4.03	6.31	9.02
Book Value	151.35	25.98	113.62	189.71	263.46	363.05
Book Value Per Share	2.28	0.48	2.18	4.41	6.47	9.01
Tangible Book Value	151.35	25.98	113.62	189.71	263.46	363.05
Tangible Book Value Per Share	2.28	0.48	2.18	4.41	6.47	9.01

Updated May 8, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q